Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable,and bioengineered human tissues. Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company was founded in 2004 and is headquartered in Durham, North Carolina.
